Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-196"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-24"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20101124.15.3-196"2
lpv:hasSubsequent	lp_eu:2010-11-24-Speech-3-1972
lpv:speaker	lp:Bart Staes2
lpv:spokenAs	member; G/EFA (2009-07-14--2014-06-30)3 vice-chair; Delegation to the EU-Kazakhstan, EU-Kyrgyzstan and EU-Uzbekistan Parliamentary Cooperation Committees, and for relations with Tajikistan, Turkmenistan and Mongolia (2009-09-29--2012-02-12)3 vice-chair; CONT (2009-07-20--2012-01-18)3 member; Delegation to the EU-Russia Parliamentary Cooperation Committee (2009-09-16--2014-06-30)3 substitute; DEVE (2009-07-16--2012-01-18)3 substitute; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 unknown; Groen (2009-07-14--2014-06-30)3 substitute; ENVI (2009-07-16--2012-01-18)3 substitute; Delegation for relations with the countries of the Andean Community (2009-09-16--2012-02-05)3
lpv:translated text	"In an age when people search for information themselves, patients must be informed clearly, objectively, reliably and well about the effects of medicinal products. Although advertising of medicinal products is banned in the Union, the Commission has created an opening. Its proposal – which I did not endorse – lacked such a strategy, and the distinction from advertising was too vague. In addition, the Commission gave too many rights and too much responsibility to the pharmaceutical industry. Now that Parliament has made major changes, however, I can support the proposal. Companies’ use of official documents (summarised product information, evaluation reports) and the channels through which they make the information available are restricted: health newspapers and magazines, websites and letters to patients are no longer permitted. All guidance on the medicinal products must be screened and approved in advance by the competent authorities. This precludes self-regulation, which the original proposal did not do. I still have my doubts about the feasibility of this proposal, as a mandatory government information strategy would still be stronger than the government monitoring companies’ policies. I nevertheless voted in favour of the legislative proposal as, at the end of the day, it does ensure better information for patients."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph